551 related articles for article (PubMed ID: 17218726)
1. Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency.
Götherström G; Bengtsson BA; Bosaeus I; Johannsson G; Svensson J
Eur J Endocrinol; 2007 Jan; 156(1):55-64. PubMed ID: 17218726
[TBL] [Abstract][Full Text] [Related]
2. Fifteen years of GH replacement increases bone mineral density in hypopituitary patients with adult-onset GH deficiency.
Elbornsson M; Götherström G; Bosæus I; Bengtsson BÅ; Johannsson G; Svensson J
Eur J Endocrinol; 2012 May; 166(5):787-95. PubMed ID: 22318746
[TBL] [Abstract][Full Text] [Related]
3. The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study.
Drake WM; Rodríguez-Arnao J; Weaver JU; James IT; Coyte D; Spector TD; Besser GM; Monson JP
Clin Endocrinol (Oxf); 2001 Apr; 54(4):525-32. PubMed ID: 11318789
[TBL] [Abstract][Full Text] [Related]
4. Effects of up to 15 years of recombinant human GH (rhGH) replacement on bone metabolism in adults with growth hormone deficiency (GHD): the Leiden Cohort Study.
Appelman-Dijkstra NM; Claessen KM; Hamdy NA; Pereira AM; Biermasz NR
Clin Endocrinol (Oxf); 2014 Nov; 81(5):727-35. PubMed ID: 24816144
[TBL] [Abstract][Full Text] [Related]
5. Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease.
Johannsson G; Sunnerhagen KS; Svensson J
Clin Endocrinol (Oxf); 2004 May; 60(5):550-9. PubMed ID: 15104557
[TBL] [Abstract][Full Text] [Related]
6. Effects of 3-year GH replacement therapy on bone mineral density in younger and elderly adults with adult-onset GH deficiency.
Elbornsson M; Götherström G; Franco C; Bengtsson BÅ; Johannsson G; Svensson J
Eur J Endocrinol; 2012 Feb; 166(2):181-9. PubMed ID: 22106341
[TBL] [Abstract][Full Text] [Related]
7. Effects of long-term treatment with GH in the bone mineral density of adults with hypopituitarism and GH deficiency and after discontinuation of GH replacement.
Gómez JM; Gómez N; Fiter J; Soler J
Horm Metab Res; 2000 Feb; 32(2):66-70. PubMed ID: 10741688
[TBL] [Abstract][Full Text] [Related]
8. Bone density and turnover in young adult patients with growth hormone deficiency after 2-year growth hormone replacement according with gender.
Rota F; Savanelli MC; Tauchmanova L; Savastano S; Lombardi G; Colao A; Di Somma C
J Endocrinol Invest; 2008 Feb; 31(2):94-102. PubMed ID: 18362499
[TBL] [Abstract][Full Text] [Related]
9. Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency.
Johannsson G; Rosén T; Bosaeus I; Sjöström L; Bengtsson BA
J Clin Endocrinol Metab; 1996 Aug; 81(8):2865-73. PubMed ID: 8768843
[TBL] [Abstract][Full Text] [Related]
10. Effect of growth hormone replacement on BMD in adult-onset growth hormone deficiency.
Snyder PJ; Biller BM; Zagar A; Jackson I; Arafah BM; Nippoldt TB; Cook DM; Mooradian AD; Kwan A; Scism-Bacon J; Chipman JJ; Hartman ML
J Bone Miner Res; 2007 May; 22(5):762-70. PubMed ID: 17280527
[TBL] [Abstract][Full Text] [Related]
11. Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency.
Biller BM; Sesmilo G; Baum HB; Hayden D; Schoenfeld D; Klibanski A
J Clin Endocrinol Metab; 2000 Mar; 85(3):970-6. PubMed ID: 10720025
[TBL] [Abstract][Full Text] [Related]
12. Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative, prospective study.
Koranyi J; Svensson J; Götherström G; Sunnerhagen KS; Bengtsson B; Johannsson G
J Clin Endocrinol Metab; 2001 Oct; 86(10):4693-9. PubMed ID: 11600527
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices.
Götherström G; Svensson J; Koranyi J; Alpsten M; Bosaeus I; Bengtsson B; Johannsson G
J Clin Endocrinol Metab; 2001 Oct; 86(10):4657-65. PubMed ID: 11600522
[TBL] [Abstract][Full Text] [Related]
14. [Long-term effects of 7-year growth hormone substitution on bone metabolism, bone density, and bone quality in growth hormone-deficient adults].
Wilhelm B; Kann PH
Med Klin (Munich); 2004 Oct; 99(10):569-77. PubMed ID: 15490072
[TBL] [Abstract][Full Text] [Related]
15. Impact of the growth hormone replacement on bone status in growth hormone deficient adults.
Kužma M; Kužmová Z; Zelinková Z; Killinger Z; Vaňuga P; Lazurová I; Tomková S; Payer J
Growth Horm IGF Res; 2014 Feb; 24(1):22-8. PubMed ID: 24382377
[TBL] [Abstract][Full Text] [Related]
16. The impact of glucocorticoid replacement on bone mineral density in patients with hypopituitarism before and after 2 years of growth hormone replacement therapy.
Ragnar Agnarsson H; Johannsson G; Ragnarsson O
J Clin Endocrinol Metab; 2014 Apr; 99(4):1479-85. PubMed ID: 24423362
[TBL] [Abstract][Full Text] [Related]
17. TRABECULAR BONE SCORE CHANGE DIFFERS WITH REGARD TO 25(OH)D LEVELS IN PATIENTS TREATED FOR ADULT-ONSET GROWTH HORMONE DEFICIENCY.
Kužma M; Binkley N; Bednárová A; Killinger Z; Vaňuga P; Payer J
Endocr Pract; 2016 Aug; 22(8):951-8. PubMed ID: 27042750
[TBL] [Abstract][Full Text] [Related]
18. Impact of growth hormone status on body composition and the skeleton.
Mukherjee A; Murray RD; Shalet SM
Horm Res; 2004; 62 Suppl 3():35-41. PubMed ID: 15539797
[TBL] [Abstract][Full Text] [Related]
19. The effects of growth hormone replacement therapy on bone metabolism in adult-onset growth hormone deficiency: a 2-year open randomized controlled multicenter trial.
Bex M; Abs R; Maiter D; Beckers A; Lamberigts G; Bouillon R
J Bone Miner Res; 2002 Jun; 17(6):1081-94. PubMed ID: 12054164
[TBL] [Abstract][Full Text] [Related]
20. Baseline characteristics and effects of growth hormone therapy over two years in younger and elderly adults with adult onset GH deficiency.
Franco C; Johannsson G; Bengtsson BA; Svensson J
J Clin Endocrinol Metab; 2006 Nov; 91(11):4408-14. PubMed ID: 16940452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
